动脉样硬化纳米颗粒药物输送系统:精确准,炎症调节和斑块稳定
Yunqi Zhang1, Feifei Li2, Libo Liu1
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, P. R. China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|August 28, 2025
概括
纳米颗粒药物递送系统 (NDDS) 通过向病变和响应斑块微环境,提供先进的动脉样硬化治疗. 与传统方法相比,这些系统提高了疗效,减少了副作用.
科学领域:
- 心血管医学
- 生物医学工程
- 纳米技术
背景情况:
- 动脉样硬化是导致心血管疾病的主要原因之一.
- 目前的治疗方法由于疾病的多面性而面临局限性.
研究的目的:
- 审查动脉样硬化的病理生理机制.
- 检查用于动脉样硬化治疗的纳米颗粒药物输送系统 (NDDS) 的进展.
主要方法:
- 对病理生理机制的系统审查.
- 对针对性动脉样硬化治疗的NDDS的最新发展进行分析.
主要成果:
- NDDS可以调节参与动脉样硬化进展的细胞活动.
- 有针对性的输送和刺激反应释放增强了治疗效果.
- NDDS可以最大限度地减少系统性和非目标性不良影响.
结论:
- NDDS克服了传统药物治疗动脉样硬化的局限性.
- 使用NDDS的个性化干预可以减轻疾病的进展,稳定斑块,并促进回归.
- NDDS具有重新定义动脉样硬化治疗模式和改善患者治疗结果的变革潜力.
相关概念视频
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Atherosclerosis I: Introduction
76
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
644
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
644
Inflammation
55.1K
Overview
55.1K
Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50


